Raptor Technology (RAPT) and Hanmi Pharmaceutical Announce Collaboration to Develop and Commercialize FLX475 in Asia

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/12/2026

1. ADBE
2. SPCX
3. USO
4. SPY
5. RH
6. NVDA
7. RKLB
8. CRM
9. MSFT
10. MRVL

Go back to Raptor Technology (RAPT) and Hanmi Pharmaceutical Announce Collaboration to Develop and Commercialize FLX475 in Asia

Raptor Technology Group, Inc. (RAPT) Announces Rodney Young as CFO

December 4, 2019 8:03 AM EST

RAPT Therapeutics, Inc. (NASDAQ: RAPT), a clinical-stage immunology-based biopharmaceutical company focused on discovering, developing and commercializing oral small molecule therapies for patients with significant unmet needs in oncology and inflammatory diseases, today announced the appointment of Rodney Young as chief financial officer effective December 2, 2019.

As a newly public company, we are thrilled to welcome Rodney to RAPT, said Brian Wong, M.D., Ph.D., president and CEO of RAPT... More